Alternatives to empagliflozin
3 same-class SPL records vs empagliflozin - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Jardiance
How to read a high-report FAERS peer set
empagliflozin ranks in the upper FAERS-volume third of the corpus (#119 of 524); 3 same-class peers are listed for field comparison only.
Top FAERS reaction fields for empagliflozin total 27,122 reports across 10 reactions, set beside canagliflozin, dapagliflozin, ertugliflozin. Counts are exposure-weighted submissions, not per-patient risk.
About empagliflozin
3 SGLT2 Inhibitor peers (wide set)
canagliflozin
RxInvokana
Invokana is used to help control blood sugar levels in adults with type 2 diabetes. It is used along with diet and exercise. Invokana can also lower the risk of major heart problems like heart attack and stroke in adults with both type 2 diabetes and heart disease. It can also reduce the risk of kidney failure, heart-related death, and hospitalization for heart failure in adults with type 2 diabetes and kidney problems.
dapagliflozin
RxFarxiga
This medicine can help adults with chronic kidney disease by reducing the risk of kidney problems, heart problems, and needing to go to the hospital for heart failure. It can also help adults with heart failure by reducing the risk of heart problems and needing urgent care for heart failure. For adults with type 2 diabetes, it can help lower the risk of needing to go to the hospital for heart failure.
ertugliflozin
RxSteglatro
empagliflozin vs canagliflozin & dapagliflozin · FAERS reaction fields
FAERS top-reaction field "Blood Glucose Increased" shows the widest count spread between empagliflozin and canagliflozin, dapagliflozin, ertugliflozin in this extract (1,182-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | empagliflozin | canagliflozin | dapagliflozin | ertugliflozin |
|---|---|---|---|---|
| Diabetic Ketoacidosis | 3,773 | 3,421 | 1,524 | 51 |
| Nausea | 3,212 | 997 | 2,218 | 86 |
| Blood Glucose Increased | 3,043 | 1,227 | 1,861 | 46 |
| Diarrhoea | 2,806 | 770 | 2,074 | 43 |
| Weight Decreased | 2,749 | 1,340 | 1,827 | - |
| Fatigue | 2,590 | - | 2,250 | 23 |
| Dizziness | 2,417 | 839 | 2,096 | 46 |
| Vomiting | 2,399 | - | 1,621 | 59 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
empagliflozin FAERS volume vs class peers
FAERS volume band
empagliflozin is FAERS corpus rank #119 of 524 (high volume tercile). Top-reaction field total: 27,122.
Frequently Asked Questions
Where does empagliflozin sit in FAERS report volume vs SGLT2 Inhibitor peers? ▼
Registry note: FAERS counts are voluntary reports and do not establish causation or risk rates. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for empagliflozin: see also the generic vs brand label guide when reading Jardiance SPL strings.
Read our methodology - how this data is sourced, computed, and verified.